|
Q3 FY2016
As of Jun 30, 2016
|
Q2 FY2016
As of Mar 31, 2016
|
Q1 FY2016
As of Dec 31, 2015
|
Q4 FY2015
As of Sep 30, 2015
|
Q3 FY2015
As of Jun 30, 2015
|
Q2 FY2015
As of Mar 31, 2015
|
Q1 FY2015
As of Dec 31, 2014
|
Q4 FY2014
As of Sep 30, 2014
|
Q3 FY2014
As of Jun 30, 2014
|
Q2 FY2014
As of Mar 31, 2014
|
Q1 FY2014
As of Dec 31, 2013
|
Q4 FY2013
As of Sep 30, 2013
|
Q3 FY2013
As of Jun 30, 2013
|
Q2 FY2013
As of Mar 31, 2013
|
Q1 FY2013
As of Dec 31, 2012
|
Q4 FY2012
As of Sep 30, 2012
|
Q2 FY2012
As of Mar 31, 2012
|
Q1 FY2012
As of Dec 31, 2011
|
Q4 FY2011
As of Sep 30, 2011
|
Q3 FY2011
As of Jun 30, 2011
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Other current assets | ||||||||||||||||||||
| Prepaid | ||||||||||||||||||||
| Inventory | ||||||||||||||||||||
| Total Current Assets | ||||||||||||||||||||
| Security deposit | ||||||||||||||||||||
| Fixed assets, net of accumulated depreciation of $2,084 | ||||||||||||||||||||
| Total Assets | ||||||||||||||||||||
| LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT) | ||||||||||||||||||||
| Current Liabilities: | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accounts payable and other accruals | ||||||||||||||||||||
| Accounts payable, related party | ||||||||||||||||||||
| Accrued officer compensation | ||||||||||||||||||||
| Deferred rent expense | ||||||||||||||||||||
| Accrued officer compensation - related party | ||||||||||||||||||||
| Accrued interest, related party | ||||||||||||||||||||
| Notes payable | ||||||||||||||||||||
| Accrued interest and penalties | ||||||||||||||||||||
| Loans payable | ||||||||||||||||||||
| Loans payable - related party | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Convertible notes (net of discount of $0 and $92,354, respectively) | ||||||||||||||||||||
| Convertible debentures in default | ||||||||||||||||||||
| Convertible notes payable, net of discount of $194,051 and $27,637, respectively | ||||||||||||||||||||
| Convertible notes payable in default | ||||||||||||||||||||
| Total Liabilities | ||||||||||||||||||||
| Stockholders' Equity (Deficit): | ||||||||||||||||||||
| Preferred Stock, $0.0001 par value, 4,980,000 shares authorized, none issued and outstanding; Series A Preferred Stock, $0.0001 par value, 5,000,000 shares authorized, 5,000,000 and 5,000,000 issued and outstanding, respectively; Series AA Preferred Stock, $0.0001 par value, 10 shares authorized, 10 and 10 issued and outstanding, respectively; Series B Preferred Stock, $0.0001 par value, 5,000,000 shares authorized, 83,268 and 57,298 issued and outstanding, respectively | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series F Preferred Stock | ||||||||||||||||||||
| Total preferred Stock, $0.0001 par value, 4,980,000 shares authorized, none issued and outstanding; Series A Preferred Stock, $0.0001 par value, 5,000,000 shares authorized, 5,000,000 and 5,000,000 issued and outstanding, respectively; Series AA Preferred Stock, $0.0001 par value, 10 shares authorized, 10 and 10 issued and outstanding, respectively; Series B Preferred Stock, $0.0001 par value, 5,000,000 shares authorized, 83,268 and 57,298 issued and outstanding, respectively | ||||||||||||||||||||
| Common stock, $0.00001 par value, 6,000,000,000 shares authorized, 323,474,377 and 67,398,079 issued and outstanding, respectively | ||||||||||||||||||||
| Additional paid in capital | ||||||||||||||||||||
| Common stock payable | ||||||||||||||||||||
| Deficit accumulated during development stage | ||||||||||||||||||||
| Series B Preferred Stock payable | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Stockholders' Equity (Deficit) | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series F Preferred Stock | ||||||||||||||||||||
| Total Stockholders' Equity (Deficit) | ||||||||||||||||||||
| Liabilities and Stockholders' Equity (Deficit) | ||||||||||||||||||||
| Series A Preferred Stock | ||||||||||||||||||||
| Series B Preferred Stock | ||||||||||||||||||||
| Series F Preferred Stock | ||||||||||||||||||||
| Total Liabilities and Stockholders' Equity (Deficit) | ||||||||||||||||||||
Loading...
